HomeAbiraterone AcetateAbiraterone Acetate + Ketoconazole

Does Abiraterone Acetate Interact with Ketoconazole?

Abiraterone Acetate and Ketoconazole have a minor drug interaction according to U.S. FDA drug labeling data. Strong CYP3A4 inhibitor had no clinically meaningful effect on abiraterone pharmacokinetics. The mechanism involves cyp3a4 inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Minor
Ketoconazole Class
Azole Antifungal
Management
Generally manageable
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Abiraterone Acetate and Ketoconazole occurs because cyp3a4 inhibition. Clinically, this means strong cyp3a4 inhibitor had no clinically meaningful effect on abiraterone pharmacokinetics. This is classified as a minor interaction with generally low clinical significance, though your healthcare provider should still be informed that you are taking both medications.

What To Tell Your Doctor or Pharmacist

If you are taking Abiraterone Acetate and your doctor is considering prescribing Ketoconazole (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Abiraterone Acetate(Abiraterone)+💊 Ketoconazole

Severity & Interaction Details

minor
Generally safe — minor interaction
Low clinical significance. Routine awareness is usually sufficient.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Azole Antifungal
Source
NLP:abiraterone acetate

What this means in plain English

Strong CYP3A4 inhibitor had no clinically meaningful effect on abiraterone pharmacokinetics.

What the FDA label says

"CYP3A4 inhibition"

📖 Source: NLP:abiraterone acetate

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Abiraterone Acetate and Ketoconazole against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.